Item 16. FORM 10-K SUMMARY

2K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.



		2017 Form 10-K \| 105

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, AbbVie Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



AbbVie Inc.
By:		/s/ RICHARD A. GONZALEZ
		Name:	Richard A. Gonzalez
		Title:	Chairman of the Board and Chief Executive Officer
Date:	February 16, 2018

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of AbbVie Inc. on February 16, 2018 in the capacities indicated below.



/s/ RICHARD A. GONZALEZ		/s/ WILLIAM J. CHASE
Richard A. Gonzalez Chairman of the Board and Chief Executive Officer (Principal Executive Officer)		William J. Chase Executive Vice President, Chief Financial Officer (Principal Financial Officer)

/s/ ROBERT A. MICHAEL
Robert A. Michael Vice President, Controller (Principal Accounting Officer)

/s/ ROBERT J. ALPERN, M.D.		/s/ ROXANNE S. AUSTIN
Robert J. Alpern, M.D. Director of AbbVie Inc.		Roxanne S. Austin Director of AbbVie Inc.

/s/ WILLIAM H.L. BURNSIDE		/s/ BRETT J. HART
William H.L. Burnside Director of AbbVie Inc.		Brett J. Hart Director of AbbVie Inc.

/s/ EDWARD M. LIDDY		/s/ MELODY B. MEYER
Edward M. Liddy Director of AbbVie Inc.		Melody B. Meyer Director of AbbVie Inc.

/s/ EDWARD J. RAPP		/s/ GLENN F. TILTON
Edward J. Rapp Director of AbbVie Inc.		Glenn F. Tilton Director of AbbVie Inc.

/s/ FREDERICK H. WADDELL
Frederick H. Waddell Director of AbbVie Inc.



106 \| 2017 Form 10-K

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES